Burke, J. M., Shustov, A., Essell, J., Patel-Donnelly, D., Yang, J., Chen, R., . . . Sharman, J. (2018). An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma. Clin Lymphoma Myeloma Leuk.
Citação norma ChicagoBurke, John M., et al. "An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma." Clin Lymphoma Myeloma Leuk 2018.
MLA CitationBurke, John M., et al. "An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma." Clin Lymphoma Myeloma Leuk 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.